NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02854072,A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients,https://clinicaltrials.gov/study/NCT02854072,,UNKNOWN,To assess treatment of GV1001 concurrent with Gemcitabine/Capecitabine versus Gemcitabine/Capecitabine alone in locally advanced and metastatic pancreatic cancer patients.,NO,Pancreatic Cancer,DRUG: GV1001|DRUG: Gemcitabine|DRUG: Capecitabine,"Overall Survival, one year","Time to tumor progression (TTP), one year|Objective response rate (ORR), Objective response rate assesses by CT scan (RECIST and irRC criteria)., one year|Clinical benefit response (CBR), one year|Clinical response with eotaxin level (baseline of serum eotaxin level, pg/mL), one year|Quality of Life using EORTC QLQ-C30, up to one year|Quality of Life using EQ-5D-3L, up to one year|Change in CA19-9 (Serum cancer antigen) over time, Cancer antigen 19-9 (CA 19-9) is used to help differentiate between cancer of the pancreas and other conditions, as well as to monitor treatment response and recurrence., one year|Toxicity according to the NCI CTCAE v4.03, one year",,"Samsung Pharmaceutical Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,148,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,KG 4/2015,2015-11,2018-05,2018-05,2016-08-03,,2016-11-22,"Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of|Wonju Severance Christian Hospital, Wonju-si, Gangwon-do, Korea, Republic of|National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of|Jeju National University Hospital, Jeju-si, Jeju-do, Korea, Republic of|Chonbuk National University Hospital, Jeonju-si, Jeollabuk-do, Korea, Republic of|Pusan National University Hospital, Busan, Korea, Republic of|Daegu Catholic University Medical Center, Daegu, Korea, Republic of|Konyang University Hospital, Daejeon, Korea, Republic of|Chonnam National University Hospital, Gwangju, Korea, Republic of|Gachon University Gil Medical Center, Incheon, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Hanyang University Seoul Hospital, Seoul, Korea, Republic of|Korea University Anam Hospital, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of",
